Rheumatoid arthritis and spondyloarthritis prevalence in four European countries - a comparative study-Reference-Cited by-同舟云学术

Rheumatoid arthritis and spondyloarthritis prevalence in four European countries - a comparative study

Published:2022 Issue:7-8 Volume:150 Page:421-427
ISSN:0370-8179
Container-title:Srpski arhiv za celokupno lekarstvo
language:en
Short-container-title:Srp Arh Celok Lek

Author:

Zlatkovic-Svenda Mirjana¹^ORCID,Saraux Alain²,Tuncer Tiraje³,Dadoniene Jolanta⁴,Miltiniene Dalia⁴,Gilgil Erdal³,Stojanovic Roksanda⁵^ORCID,Guillemin Francis⁶

Affiliation:

1. University of Belgrade, Faculty of Medicine, Institute of Rheumatology, Belgrade, Serbia + University of East Sarajevo, Faculty of Medicine, Sarajevo, Republic of Srpska, Bosnia and Herzegovina

2. Université de Brest, Rheumatology, Le centre hospitalier régional universitaire (CHU) Brest and UMR, Lymphocytes B et Autoimmunité, LabEx IGO, Brest, France

3. University of Akdeniz, Faculty of Medicine, Department of Physical Medicine, Rehabilitation, and Rheumatology, Antalya, Turkey

4. State Research Institute Centre for Innovative Medicine, Vilnius, Lithuania + University of Vilnius, Medical Faculty, Vilnius, Lithuania

5. University of Belgrade, Faculty of Medicine, Institute of Rheumatology, Belgrade, Serbia

6. Université de Lorraine, EA Apemac, Nancy, France + Inserm, CHRU Nancy, CIC- Epidémiologie Clinique, Nancy University hospital, Nancy, France

Abstract

Introduction/Objective. The objective was to compare rheumatoid arthritis (RA), spondyloarthritis (SpA) and subtypes of SpA prevalence in four European countries. Methods. A 33-items detection questionnaire, containing self-reported diagnosis, classification criteria for RA and SpA, personal and family history, was translated using cross-cultural adaptation and validated in France, Turkey, Lithuania and Serbia, where it was used on a population sample. Suspected cases were evaluated and confirmed by a rheumatologist. Prevalence estimates were age- and sex-standardized to European standard population. Results. In total, 33,454 people older than 18 years were screened and 31,454 interviewed: France 14,671, Lithuania 6,558, Serbia 6,213, Turkey 4,012. Standardized RA prevalence varied from 0.29% (95% CI: 0.17?0.40) in France to 0.57% (0.31?0.84) in Turkey; this inequality was mostly caused by differences in women prevalence (from 0.42% in France to 1.02% in Turkey) SpA prevalence was similar in France (0.30%), Serbia (0.35%) and Turkey (0.37%), but in Lithuania it was 0.89%, which could be caused by geographic and genetic differences, as SpA prevalence was higher in North and East Europe, as well as the human leukocyte antigen B27 presence. SpA prevalence was equally presented by gender for France and Serbia. Regarding SpA subtypes, ankylosing spondylitis prevalence varied from 0.07?0.30% (Serbia?Lithuania), PsA 0.10?0.26% (France?Lithuania), reactive arthritis was 0.09?0.18% (Serbia?Lithuania). Previously nondiagnosed SpA cases were found in 6.9% in France, 25.9% in Lithuania and 31.2% in Serbia. Conclusion. East?West decreasing tendency for the female RA prevalence was noted. SpA was higher in North-Eastern Europe than in its Western and Southern part. One quarter of the SpA patients in Lithuania and one third in Serbia were not previously diagnosed. The SpA population prevalence was higher than expected and similar to RA.

Publisher

National Library of Serbia

Subject

General Medicine

Reference30 articles.

1. Zlatkovic-Svenda M, Stojanovic R, Sipetic-Grujicic S, Guillemin F. Prevalence of rheumatoid arthritis in Serbia. Rheumatol Int. 2014;34(5):649-58. [DOI: 10.1007/s00296-013-2897-7] [PMID: 24292809]

2. Zlatkovic-Svenda M, Stojanovic R, Sipetic-Grujicic S, Radak-Perovic M, Guillemin F. Prevalence of spondyloarthritis and its subtypes - are they really comparable? Srp Arh Celok Lek. 2019;147(3-4):235- 42. [DOI: 10.2298/SARH180110009Z] [PMID: 10910180]

3. Alamanos Y, Voulgari P, Drosos A. Incidence and prevalence of rheumatoid arthritis, based on the 1987 American College of Rheumatology criteria: a systematic review. Semin Arthritis Rheum. 2006;36(3):182-8. [DOI: 10.1016/j.semarthrit.2006.08.006] [PMID: 17045630]

4. Batko B, Stajszczyk M, Świerkot J, Urbański K, Raciborski F, Jędrzejewski M. Prevalence and clinical characteristics of rheumatoid arthritis in Poland: a nationwide study. Arch Med Sci. 2019;15(1):134-40. [DOI: 10.5114/aoms.2017.71371] [PMID: 30697263]

5. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO, et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/ European League Against Rheumatism collaborative initiative. Ann Rheum Dis. 2010;69(9):1580-8. [DOI: 10.1002/art.27584] [PMID: 20872595]